These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9001799)

  • 21. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of androgen insensitivity.
    Brinkmann AO
    Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
    Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of the androgen receptor gene in 4 patients with complete androgen insensitivity.
    Komori S; Kasumi H; Sakata K; Tanaka H; Hamada K; Koyama K
    Arch Gynecol Obstet; 1998; 261(2):95-100. PubMed ID: 9544375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.
    Brown TR; Migeon CJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):542-50. PubMed ID: 3944238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
    Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype versus phenotype in families with androgen insensitivity syndrome.
    Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome.
    Dörk T; Schnieders F; Jakubiczka S; Wieacker P; Schroeder-Kurth T; Schmidtke J
    Hum Mutat; 1998; 11(4):337-9. PubMed ID: 9554754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor gene mutation associated with complete androgen insensitivity syndrome and Sertoli cell adenoma.
    Ko HM; Chung JH; Lee JH; Jung IS; Choi IS; Juhng SW; Choi C
    Int J Gynecol Pathol; 2001 Apr; 20(2):196-9. PubMed ID: 11293168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel and recurrent mutations in patients with androgen insensitivity syndromes.
    Ledig S; Jakubiczka S; Neulen J; Aulepp U; Burck-Lehmann U; Mohnike K; Thiele H; Zierler H; Brewer C; Wieacker P
    Horm Res; 2005; 63(6):263-9. PubMed ID: 15925895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
    De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
    Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
    Radmayr C; Culig Z; Hobisch A; Corvin S; Bartsch G; Klocker H
    Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete androgen insensitivity with a normal amount of 5 alpha-dihydrotestosterone-binding activity in labium majus skin fibroblasts.
    Kaufman M; Pinsky L; Baird PA; McGillivray BC
    Am J Med Genet; 1979; 4(4):401-11. PubMed ID: 575468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete androgen insensitivity caused by a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene.
    Thiele B; Weidemann W; Schnabel D; Romalo G; Schweikert HU; Spindler KD
    J Clin Endocrinol Metab; 1999 May; 84(5):1751-3. PubMed ID: 10323411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor.
    Holterhus PM; Hiort O; Demeter J; Brown PO; Brooks JD
    Genome Biol; 2003; 4(6):R37. PubMed ID: 12801411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays.
    Avila DM; Wilson CM; Nandi N; Griffin JE; McPhaul MJ
    J Clin Endocrinol Metab; 2002 Jan; 87(1):182-8. PubMed ID: 11788645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of androgen insensitivity.
    Brüggenwirth HT; Boehmer AL; Verleun-Mooijman MC; Hoogenboezem T; Kleijer WJ; Otten BJ; Trapman J; Brinkmann AO
    J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):569-75. PubMed ID: 8918984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.